FlyUSA Expands Its Private Aviation Services with New Jet Card Debut
Private flying customers can experience predictable excellence with the FlyUSA Freedom Jet Card
FlyUSA's
FlyUSA Freedom Jet Card owners receive:
- Financial Security: Funds are securely held in a restricted account until fully earned on an individual flight basis.
- Flexibility: Control over travel budget, providing options on when and where to go.
- Predictability: Clients know exactly what they're paying for with straightforward, competitive rates.
- No minimums: Deposit-based access to private aviation, providing unmatched flexibility and convenience.
Learn more about the Freedom Jet Card here.
"This has been an incredibly successful year for our company, marked by innovation, accolades and growth," said
Since its inception, FlyUSA has prioritized building a culture of safety combined with the belief that private aviation should be responsive, personalized and easy. Founded by experienced pilots and with a focus on providing high-touch services, FlyUSA has established itself as a leader in the private aviation industry. The company's revenue has surged by 40% year-over-year, driving the expansion of its service offerings to include global private flight charters, aircraft memberships, jet cards, aircraft partnerships, ownership and management.
About FlyUSA
FlyUSA offers a range of private aviation services, including charter flights, the Ascend Club Membership Program, jet card programs and aircraft management. With a focus on safety and personalized service, FlyUSA has become one of the fastest-growing private companies in the
For more information, visit FlyUSA.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/flyusa-expands-its-private-aviation-services-with-new-jet-card-debut-302328073.html
SOURCE FlyUSA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hanyang University Researchers Achieve Controllable Doping in Organic Semiconductors
- Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
- Arkema: Statement About the Number of Shares and Voting Rights in Compliance With the Article L.233-8 II of the French Commercial Code and the Article 223-16 of the Financial Markets Authority (AMF-Au
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
ArgusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share